Marcos Minicucci

Dr. Marcos Minicucci


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in Journal of Critical Care
Verified
Journal Article
Closed access
NCNara Aline Costa
Nara Aline Costa
AGAna Lúcia Gut
Ana Lúcia Gut
MDMariana de Souza Dorna
Mariana de Souza Dorna
JPJosé Alexandre Coelho Pimentel
José Alexandre Coelho Pimentel
SCSilvia Maria Franciscato Cozzolino
Silvia Maria Franciscato Cozzolino
MMMarcos Minicucci
Marcos Minicucci

29 December 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
TLTaline Lazzarin
Taline Lazzarin
CTCarolina Rodrigues Tonon
Carolina Rodrigues Tonon
DMDanilo Martins
Danilo Martins
EJEdson Favero Junior
Edson Favero Junior
TBThiago Dias Baumgratz
Thiago Dias Baumgratz
MMMarcos Minicucci
Marcos Minicucci
Cardiac arrest is an important public health issue, with a survival rate of approximately 15 to 22%. A great proportion of these deaths occur after resuscitation due to post-cardiac arrest syndrome, which is characterized by the ischemia-reperfusion injury that affects the role body. Understanding physiopathology is mandatory to discover new treatment strategies and obtain better results. Besides improvements in cardiopulmonary resuscitation maneuvers, the great increase in survival rates observed in recent decades is due to new approaches to post-cardiac arrest care. In this review, we will discuss physiopathology, etiologies, and post-resuscitation care, emphasizing targeted temperature management, early coronary angiography, and rehabilitation.

28 September 2012 in British Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
DGDavid N. Gumieiro
David N. Gumieiro
BRBruna P. M. Rafacho
Bruna P. M. Rafacho
AGAndrea F. Gonçalves
Andrea F. Gonçalves
SMSuzana Minamoto
Suzana Minamoto
PAPaula Azevedo
Paula Azevedo
MMMarcos Minicucci
Marcos Minicucci
The aim of the present study was to evaluate the Mini Nutritional Assessment (MNA), the Nutritional Risk Screening (NRS) 2002 and the American Society of Anesthesiologists Physical Status Score (ASA) as predictors of gait status and mortality 6 months after hip fracture. A total of eighty-eight consecutive patients over the age of 65 years with hip fracture admitted to an orthopaedic unit were prospectively evaluated. Within the first 72 h of admission, each patient's characteristics were recorded, and the MNA, the NRS 2002 and the ASA were performed. Gait status and mortality were evaluated 6 months after hip fracture. Of the total patients, two were excluded because of pathological fractures. The remaining eighty-six patients (aged 80·2 (sd 7·3) years) were studied. Among these patients 76·7 % were female, 69·8 % walked with or without support and 12·8 % died 6 months after the fracture. In a multivariate analysis, only the MNA was associated with gait status 6 months after hip fracture (OR 0·773, 95 % CI 0·663, 0·901; P= 0·001). In the Cox regression model, only the MNA was associated with mortality 6 months after hip fracture (hazard ratio 0·869, 95 % CI 0·757, 0·998; P= 0·04). In conclusion, the MNA best predicts gait status and mortality 6 months after hip fracture. These results suggest that the MNA should be included in the clinical stratification of patients with hip fracture to identify and treat malnutrition in order to improve the outcomes.

30 November 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
DMDanilo Martins
Danilo Martins
LGLeonardo Rufino Garcia
Leonardo Rufino Garcia
DQDiego Queiroz
Diego Queiroz
TLTaline Lazzarin
Taline Lazzarin
CTCarolina Rodrigues Tonon
Carolina Rodrigues Tonon
Leonardo ZornoffLeonardo Zornoff
Leonardo Zornoff
Cardiac remodeling is defined as a group of molecular, cellular, and interstitial changes that clinically manifest as changes in the heart’s size, mass, geometry, and function after different stimuli. It is important to emphasize that remodeling plays a pathophysiological role in the onset and progression of ventricular dysfunction and subsequent heart failure. Therefore, strategies to mitigate this process are critical. Different factors, including neurohormonal activation, can regulate the remodeling process and increase cell death, alterations in contractile and regulatory proteins, alterations in energy metabolism, changes in genomics, inflammation, changes in calcium transit, metalloproteases activation, fibrosis, alterations in matricellular proteins, and changes in left ventricular geometry, among other mechanisms. More recently, the role of reactive oxygen species and oxidative stress as modulators of remodeling has been gaining attention. Therefore, this review assesses the role of oxidative stress as a therapeutic target of cardiac remodeling.

1 August 2017 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
BPBruna L.B. Pereira
Bruna L.B. Pereira
PRPatricia Reis
Patricia Reis
FSFábio E. Severino
Fábio E. Severino
TFTainara F. Felix
Tainara F. Felix
MBMariana G. Braz
Mariana G. Braz
MMMarcos Minicucci
Marcos Minicucci

1 January 2010 in Cellular Physiology and Biochemistry
Verified
Journal Article
Open access
PDF file
MMMarcos Minicucci
Marcos Minicucci
PAPaula Azevedo
Paula Azevedo
SOSilvio Oliveira-Junior
Silvio Oliveira-Junior
Paula MartinezPaula Martinez
Paula Martinez
FCFernanda Chiuso-Minicucci
Fernanda Chiuso-Minicucci
Leonardo ZornoffLeonardo Zornoff
Leonardo Zornoff
The role of tissue vitamin-A insufficiency on post-infarction ventricular remodeling is unknown. We tested the hypothesis that cardiac vitamin A insufficiency on post-infarction is associated with adverse myocardial remodeling. After infarction, rats were allocated into two groups: C (controls, n=25); VA (dietary vitamin A restriction, n= 26). After 3 months, the animals were submitted to echocardiogram, morphometric and biochemical analysis. Rats fed the vitamin-A-deficient diet had lower heart and liver retinol concentration and normal plasma retinol. There were no differences in infarct size between the groups. VA showed higher diastolic left ventricular area normalised by body weight (C= 1.81 ± 0.4 cm2/kg, VA= 2.15 ± 0.3 cm2/kg; p=0.03), left ventricular diameter (C= 9.4 ± 1.4 mm, VA= 10.5 ± 1.2 mm; p=0.04), but similar systolic ventricular fractional area change (C= 33.0 ± 10.0 %, VA= 32.1 ± 8.7 %; p=0.82). VA showed decreased isovolumetric relaxation time normalised by heart rate (C= 68.8 ± 11.4 ms, VA= 56.3 ± 16.8 ms; p=0.04). VA showed higher interstitial collagen fraction (C= 2.8 ± 0.9 %, VA= 3.7 ± 1.1 %; p=0.05). There were no differences in myosin heavy chain expression, metalloproteinase 2 and 9 activation, or IFN-γ and TNF-α cardiac levels. Local tissue vitamin A insufficiency intensified ventricular remodeling after MI, worsening diastolic dysfunction.